DocGo (NASDAQ:DCGO – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a research report issued to clients and investors on Tuesday,Benzinga reports. They currently have a $4.00 target price on the stock. Needham & Company LLC’s price objective points to a potential upside of 54.14% from the stock’s previous close.
Several other equities research analysts also recently commented on DCGO. Stifel Nicolaus reduced their target price on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a report on Friday, February 28th. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and cut their price target for the company from $5.00 to $2.85 in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, DocGo has an average rating of “Moderate Buy” and an average price target of $4.89.
View Our Latest Report on DCGO
DocGo Price Performance
Hedge Funds Weigh In On DocGo
Institutional investors have recently bought and sold shares of the stock. Summit Investment Advisors Inc. boosted its holdings in DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after acquiring an additional 2,968 shares during the period. Centiva Capital LP bought a new position in shares of DocGo during the third quarter valued at $43,000. Prudential Financial Inc. acquired a new position in DocGo in the fourth quarter valued at about $55,000. Royce & Associates LP acquired a new position in shares of DocGo in the 4th quarter worth approximately $64,000. Finally, Boothbay Fund Management LLC lifted its position in DocGo by 154.9% during the 4th quarter. Boothbay Fund Management LLC now owns 27,445 shares of the company’s stock worth $116,000 after buying an additional 77,445 shares in the last quarter. 56.44% of the stock is currently owned by institutional investors.
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Articles
- Five stocks we like better than DocGo
- Financial Services Stocks Investing
- PayPal Stock: Too Cheap to Ignore, Too Strong to Miss
- 5 discounted opportunities for dividend growth investors
- Progress Software: Making Progress Driven by the AI Revolution
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Intel-Taiwan Semiconductor Alliance Fuels Turnaround Hopes
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.